SCHEMBL6454535

SCHEMBL6454535

CC1CCN(CCC(N2CCC(C)CC2)n2c(=O)sc3ccccc32)CC1

nearest known ligand 0.46

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7067261 0.81 CHRM1 (0.45)
SCHEMBL2150290 0.77 HTR1A (0.66)
SCHEMBL2149429 0.77 SIGMAR1 (0.64) SIGMAR1
SCHEMBL3028533 0.77 DRD2 (0.60)
SCHEMBL7062216 0.73 SIGMAR1 (0.48) SIGMAR1
SCHEMBL7131386 0.66 CHRM1 (0.42)
SCHEMBL6466262 0.65 MEN1 (0.49)
SCHEMBL5956419 0.65 SLC6A2 (0.52)
SCHEMBL2149110 0.64 DRD2 (0.54)
SCHEMBL8870136 0.64 HTR1A (0.68)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432420-A4 BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS ACADIA PHARM INC (US) 2005-11-09 EP disclosed
EP-1432420-A2 BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS Acadia Pharmaceuticals Inc. (US) 2004-06-30 EP disclosed
WO-2003028650-A2 BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS ACADIA PHARMACEUTICALS, INC. (US) 2003-04-10 WO disclosed